Department of Radiation and Cellular Oncology and Ludwig Center for Metastasis Research
Samuel Hellman has not added Biography.
If you are Samuel Hellman and would like to personalize this page please email our Author Liaison for assistance.
An evidence-based analysis of the management of localized prostate cancer.
Cancer journal (Sudbury, Mass.) Jan-Feb, 2002 | Pubmed ID: 11895202
Transcriptional control of viral gene therapy by cisplatin.
The Journal of clinical investigation Aug, 2002 | Pubmed ID: 12163460
Radiation-induced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapy.
The Lancet. Oncology Nov, 2002 | Pubmed ID: 12424068
Sentinel lymph node versus axillary lymph node dissection for early-stage breast carcinoma: a comparison using a utility-adjusted number needed to treat analysis.
Cancer Jan, 2003 | Pubmed ID: 12518360
Consensus statement: Expedition Inspiration fund for breast cancer research meeting 2002.
Breast cancer research and treatment Mar, 2003 | Pubmed ID: 12611465
Receiver operating characteristic analysis: a general tool for DNA array data filtration and performance estimation.
Genomics Feb, 2003 | Pubmed ID: 12620398
Early prostate cancer: clinical decision-making.
Lancet (London, England) Mar, 2003 | Pubmed ID: 12660074
Expedition Inspiration Fund for Breast Cancer Research Meeting 2003.
Breast cancer research and treatment Jul, 2003 | Pubmed ID: 12908816
Hormone therapy adjuvant to external beam radiotherapy for locally advanced prostate carcinoma: a complication-adjusted number-needed-to-treat analysis.
Cancer Dec, 2003 | Pubmed ID: 14635069
Letrozole in breast cancer.
The New England journal of medicine Feb, 2004 | Pubmed ID: 14971060
The natural history of breast carcinoma in the elderly: implications for screening and treatment.
Cancer May, 2004 | Pubmed ID: 15112260
Excision margins in high-risk malignant melanoma.
The New England journal of medicine May, 2004 | Pubmed ID: 15163784
Chemoinducible gene therapy: a strategy to enhance doxorubicin antitumor activity.
Molecular cancer therapeutics Sep, 2004 | Pubmed ID: 15367711
Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment.
International journal of oncology Dec, 2004 | Pubmed ID: 15547705
Hormone therapy and radiotherapy for early prostate cancer: a utility-adjusted number needed to treat (NNT) analysis.
International journal of radiation oncology, biology, physics Mar, 2005 | Pubmed ID: 15708246
Debunking dogma and developing theses.
European journal of cancer (Oxford, England : 1990) Mar, 2005 | Pubmed ID: 15737551
Premise, promise, paradigm and prophesy.
Nature clinical practice. Oncology Jul, 2005 | Pubmed ID: 16075785
Importance of local control in an era of systemic therapy.
Nature clinical practice. Oncology Feb, 2005 | Pubmed ID: 16264859
Evolving paradigms and perceptions of cancer.
Nature clinical practice. Oncology Dec, 2005 | Pubmed ID: 16341117
Irwin Freedberg and the changing times of academic medicine.
The Journal of investigative dermatology Mar, 2006 | Pubmed ID: 16482183
Unintended consequences.
Nature clinical practice. Oncology Aug, 2007 | Pubmed ID: 17657250
Early prostate cancer: hedonic prices model of provider-patient interactions and decisions.
International journal of radiation oncology, biology, physics Mar, 2008 | Pubmed ID: 17881151
Stem-cell biology and cancer therapy: the more things change...
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Feb, 2008 | Pubmed ID: 18281648
An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease.
Clinical cancer research : an official journal of the American Association for Cancer Research Aug, 2008 | Pubmed ID: 18698045
Advances in radiotherapy and implications for the next century: a historical perspective.
Cancer research Jan, 2009 | Pubmed ID: 19147546
On first looking into Kutcher's "Contested Medicine": ethical tensions in clinical research.
Perspectives in biology and medicine , 2010 | Pubmed ID: 20495265
Oligometastases revisited.
Nature reviews. Clinical oncology Jun, 2011 | Pubmed ID: 21423255
Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease.
Cancer Jun, 2012 | Pubmed ID: 22020702
MicroRNA expression characterizes oligometastasis(es).
PloS one , 2011 | Pubmed ID: 22174856
Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs.
PloS one , 2012 | Pubmed ID: 23251360
Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Apr, 2013 | Pubmed ID: 23460715
Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs.
Clinical & experimental metastasis Aug, 2014 | Pubmed ID: 24968866
Learning while caring: medicine's epistemology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Sep, 2014 | Pubmed ID: 25092776
Clinical cancer research: the past, present and the future.
Nature reviews. Clinical oncology Nov, 2014 | Pubmed ID: 25245981
14q32-encoded microRNAs mediate an oligometastatic phenotype.
Oncotarget Feb, 2015 | Pubmed ID: 25686838
Imaging of tumor clones with differential liver colonization.
Scientific reports Jun, 2015 | Pubmed ID: 26094901
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.
Mayo Clinic proceedings Aug, 2015 | Pubmed ID: 26211600
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved